Chase AIPricingFAQs
Display currency
Loading news…

Constantiam Biosciences

ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 HighHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 High growthGrowth score — momentum trend across web traffic, headcount and other growth signals.
Watertown, Massachusetts, United States Founded 2020 1-10 employees For Profit

Preclinical biotech with deep expertise in functional genomics to map genetic variants and advance a rare disease pipeline led by CB-001.

Total Funding
Available in Pro
Last Funding
Available in Pro
Acquisitions
0
Monthly Visits
Available in Pro
Contacts
5

Company Details

Funding & Financials

Pro
Total funding
Funding rounds
Last funding
Last funding type
Last funding date
Funding status
Total equity funding
Revenue range

IPO & Stock

IPO status
Private

Web Traffic

Pro
Monthly visits
Global traffic rank
6-mo avg visits
Visit duration (s)
Pages / visit
Bounce rate
Rank change (mo)

Technology & IP

Active technologies
5
IT spend
$255K

Company Info

Founded
2020
Employees
1-10
Operating status
Active
Company type
For Profit
Org types
company
Founders
3
News articles
4
HQ
Watertown, Massachusetts, United States
Region
Greater Boston Area, East Coast, New England

Signals & Scores

Heat score
High
Growth score
High
Trend (7d)
-0.4
Trend (30d)
7.1
Trend (90d)
8.3

Key People at Constantiam Biosciences

Co-Founder & CCO
Co-Founder & CSO
5
professional contacts at Constantiam Biosciences
Contact execs at Constantiam Biosciences

Explore 200,000+ acquisitions — free

Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.

Explore all acquisitions

Recent News related to Constantiam Biosciences

Loading news…

FAQs about Constantiam Biosciences

People who checked this page also checked these

Browse the full Acquirezy directory.
Constantiam Biosciences - Company Profile, Full Acquisitions List, Funding and Investments